Granted Patent
Utility
US 6,573,276
· Confirmation No. 6867
MUSCARINIC M1 AGONIST AS AN INHIBITOR OF BETA-AMYLOID (ABETA40 AND ABETA42)-SYNTHESIS
Inventors
Christoph Hock
Erlenbach, SWITZERLAND
Andreas Raschig
Biberach, GERMANY
Marion Wienrich
Weiterstadt, GERMANY
Roger Nitsch
Zollikon, SWITZERLAND
Klaus Mendla
Ingelheim, GERMANY
Dieter Horst Meier
Marlow Buckinghamshire, UNITED KINGDOM
Klaus Bornemann
Ingelheim, GERMANY
Cornelia Dorner-Ciossek
Ingelheim, GERMANY
Attorneys & Agents of Record
Classification
USPC
514/305
A61K31/439
Prosecution
- Examiner
- SPIVACK, PHYLLIS G
- Art Unit
- 1614
- Customer No.
- 28501
- Docket No.
- 01-1205
- Confirmation No.
- 6867
Publication
- Pub. No.
- US20030050221A1
- Pub. Date
- 2003-03-13
Patent Term Adjustment
0days
CHANGE OF NAME
Recorded 2005-02-07
CHANGE OF NAME
Recorded 2004-06-28
from
BORNEMANN, KLAUS,
WIENRICH, MARION,
HOCK, CHRISTOPH,
NITSCH, ROGER,
MEIER, DIETER HORST,
DORNER-CIOSSEK, CORNELIA,
RASCHIG, ANDREAS,
MENDLA, KLAUS
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2002-10-01
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- Patent No.
- US 6,573,276
- App. No.
- 10/135,808
- Filed
- 2002-04-30
- Granted
- 2003-06-03
- Pub. No.
- US20030050221A1
- Examiner
- SPIVACK, PHYLLIS G
- Art Unit
- 1614
- PTA
- 0 days
External Links